- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06847113
Maximal and Self-selected Walkingspeed After Knee Arthroplasty - a Prospective Cohort Study (LOVKNEE)
MAXIMAL and SELF-SELECTED WALKING SPEED AFTER KNEE ARTHROPLASTY
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Brita Stanghelle, PhD
- Phone Number: +47 97514751
- Email: brita.stanghelle@oslomet.no
Study Locations
-
-
-
Oslo, Norway
- Recruiting
- Lovisenberg Diaconal Hospital
-
Contact:
- Brita Stanghelle, PhD
- Phone Number: +47 97514751
- Email: brita.stanghelle@lds.no
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria: age 55 +, living in or near the city of Oslo (up to appox 2 hours commute), sceduled for primary knee arthroplasty, able to walk independently with or without walking aids, understand and speak Norwegian sufficently to take instructions and respond to questionnaires
Exclusion Criteria:
Other reasons than osteoarthritis for knee arthroplasty, revision due to infection or failure, arthroplasty in the same or other limb during the 12 months time period, severe neurological or ohter types of disease that affects walking (e.g MS; parkinsonism, hemiplegiea)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Persons scheduled for knee arthroplasty
Age 55 or over, scheduled for primary uni or total knee arthroplasty, able to walk indepentdently with or without walkingaids, living in the eastern part of Norway within 1-2 hours commute from Oslo, able understand Norwegian for instructions and filling out forms,
|
Observe walking speed, both maximal and self-selected, over a 12-months period after knee arthroplasty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline to 3 and 12 months in means in maximal and self-selected walking speed walikgn
Time Frame: Baseline, 3 months and 12 months after surgery
|
Walking speed will be measured by 10 meter self-selected and maximal walking speed, respectively.
Participant will perform two repetitions of self-selected walking speed, followed by two repetitions of maximal walking speed.
Mean, measured by meters per seconds, will be calculated onboth of the two different walking speeds.
|
Baseline, 3 months and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sit-to-stand
Time Frame: Baseline, 3 months and 12 months after surgery
|
Lower extremity strength will be measured by 30 sec sit to stand.
Number of standing up in 30 seconds will be counted and recorded
|
Baseline, 3 months and 12 months after surgery
|
|
One legged stance
Time Frame: Baseline, 3 months and 12 months after surgery
|
Balance will be measured by one legged stance.
The participant will perform the test by standing on one leg and the other in 90 degrees flexion of the hip and knee, hands on hips.
The test will be performed twice, with the non-affected leg to be tested first.
The best of the two scores for each leg will be recorded.
|
Baseline, 3 months and 12 months after surgery
|
|
Knee specific function and pain
Time Frame: Baseline and 12 months
|
Pain and function in the knee will be measured by the patient reported form KOOS which includes 42 questions evaluating pain and function in different activities in daily life the last week.
|
Baseline and 12 months
|
|
EQ5D- Health-related quality of life
Time Frame: Baseline and 12 months after surgery
|
Measures self-reported health-related quality of life.
|
Baseline and 12 months after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity
Time Frame: Baseline and 12 months after surgery
|
To measure physical activity UCLA activity score will be applied.
UCLA is a simple scale from 1 to 10 where the participant mark the level that suits their level of activity best. 1 is the lowest, 10 the highest score.
|
Baseline and 12 months after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 764176
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Arthroplasty, Total
-
Cedars-Sinai Medical CenterPacira Pharmaceuticals, IncEnrolling by invitationTotal Knee Arthroplasty | Total Knee Arthroplasty RecoveryUnited States
-
Limacorporate S.p.aRecruitingTotal Knee Arthroplasty | Revision Total Knee ArthroplastyUnited Kingdom, Portugal, Slovakia
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
Copenhagen University Hospital, HvidovreUniversity of Southern Denmark; University Hospital Bispebjerg and FrederiksbergNot yet recruitingKnee Arthroplasty | Total Knee Arthroplasty | Unicompartmental Knee Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
-
The Affiliated Hospital Of Southwest Medical UniversityCompletedTotal Knee Arthroplasty | Total Hip Arthroplasty | ERASChina
-
Istanbul UniversityCompleted
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
Clinical Trials on Physical function
-
Hellenic Mediterranean UniversityCompletedFrailty Syndrome | Pre-frail Older AdultsGreece
-
Universidad Europea de MadridHospital Universitario Ramon y CajalNot yet recruitingDeglutition Disorders | Mechanical Ventilation Complication | Dysphagia, Oropharyngeal
-
University of Castilla-La ManchaConsorcio Centro de Investigación Biomédica en Red (CIBER)RecruitingAging | Physical Disability | Frailty Syndrome | Physical Function | Lifestyle, SedentarySpain
-
Hacettepe UniversityCompletedBurn Scar | Burns | Lower Limb Injury | Lower Limb WoundTurkey
-
University of New MexicoNational Cancer Institute (NCI)Completed
-
Cardenal Herrera UniversityConsorci Sanitari de Terrassa. Hospital de TerrassaCompletedEnd Stage Renal Disease on DialysisSpain
-
Wake Forest University Health SciencesCompleted
-
M.D. Anderson Cancer CenterCompleted
-
MinYoung Kim, MD, PhDNot yet recruitingPatients With Mild Cognitive Impairment (MCI)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Graft Versus Host DiseaseUnited States